Vimarsana
Biggest News Aggregation in the World

Page 34 - Biomedical Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biomedical Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biomedical Technology Today - Breaking & Trending Today

Russia's Sputnik V vaccine 91.6% effective — Lancet study - Vimarsana News

Russia's Sputnik V vaccine 91.6% effective — Lancet study

Russia's Sputnik V vaccine 91.6% effective — Lancet study By AFP - Feb 02,2021 - Last updated at Feb 02,2021 This handout file photo taken on August 6, 2020 and provided by the Russian Direct Investment Fund shows the vaccine against the coronavirus disease (Sputnik V), developed by the Gamaleya Research Institute of Epidemiology and Microbiology (AFP photo) PARIS — Russia's Sputnik V vaccine is 91.6 per cent effective against symptomatic COVID-19, according to results published in The Lancet on Tuesday that independent experts said allayed transparency concerns over the jab, which Moscow...

Russia's Sputnik V vaccine 91.6% effective Lancet study - Vimarsana News

Russia's Sputnik V vaccine 91.6% effective Lancet study

Russia’s Sputnik V vaccine 91.6% effective Lancet study Russia’s Sputnik V vaccine 91.6% effective Lancet study WORLD: Russia’s Sputnik V vaccine is 91.6% effective against symptomatic COVID-19, according to results published in The Lancet yesterday (Feb 2) that independent experts said allayed transparency concerns over the jab, which Moscow is already rolling out. Wednesday 3 February 2021, 10:06AM Experts had raised concerns about undue haste and a lack of transparency with the Sputnik V vaccine. Photo: AFP. Sputnik V - named after the Soviet-era satellite - was approved in Russia mo...

Russia's Sputnik V vaccine 91.6% effective, study says - Vimarsana News

Russia's Sputnik V vaccine 91.6% effective, study says

47 shares A Russian medical worker, right, administers a shot of Russia's Sputnik V coronavirus vaccine in Moscow, Russia, Saturday, Dec. 5, 2020. (AP Photo/Pavel Golovkin) Russia’s Sputnik V vaccine is 91.6 percent effective against symptomatic COVID-19, according to results published in The Lancet medical journal on Tuesday that independent experts said allayed transparency concerns over the shot, which Moscow is already rolling out. Sputnik V — named after the Soviet-era satellite — was approved in Russia months before results from its final-stage clinical trials were published...

SAMAA - Russia's Sputnik V vaccine 91.6% effective against coronavirus: Lancet study - Vimarsana News

SAMAA - Russia's Sputnik V vaccine 91.6% effective against coronavirus: Lancet study

Russia’s Sputnik V vaccine 91.6% effective against coronavirus: Lancet study It is among the world's top-performing vaccines SAMAA | AFP - Posted: Feb 2, 2021 | Last Updated: 2 months ago SAMAA | AFP Posted: Feb 2, 2021 | Last Updated: 2 months ago Vials of Sputnik V vaccine at a Belgrade vaccination centre. The jab is similar to the Oxford/AstraZeneca vaccine and based on modified version of common cold virus. Photo: AFP Listen to the story Russia's Sputnik V vaccine is 91.6% effective against symptomatic Covid-19, according to results published in The Lancet on Tuesday that ...

Source: samaa.tv
Russia's Sputnik Covid vaccine 91.6 per cent effective, according to Lancet - Vimarsana News

Russia's Sputnik Covid vaccine 91.6 per cent effective, according to Lancet

The Sputnik vaccine has been transported around the world Credit: REUTERS/Agustin Marcarian/File Photo Russia's Sputnik V vaccine is 91.6 percent effective against symptomatic Covid-19, according to results published in The Lancet on Tuesday that independent experts said allayed transparency concerns over the jab, which Moscow is already rolling out. Sputnik V - named after the Soviet-era satellite - was approved in Russia months before results from its final-stage clinical trials were published, leading to scepticism from experts. But the new analysis of data from 20,000 participants in P...